Skip to main content

Induced overexpression of phospholemman S68E mutant improves cardiac contractility and mortality after ischemia-reperfusion.

Publication ,  Journal Article
Wang, J; Song, J; Gao, E; Zhang, X-Q; Gu, T; Yu, D; Koch, WJ; Feldman, AM; Cheung, JY
Published in: Am J Physiol Heart Circ Physiol
April 1, 2014

Phospholemman (PLM), when phosphorylated at Ser(68), inhibits cardiac Na+ / Ca2+ exchanger 1 (NCX1) and relieves its inhibition on Na+ -K+ -ATPase. We have engineered mice in which expression of the phosphomimetic PLM S68E mutant was induced when dietary doxycycline was removed at 5 wk. At 8-10 wk, compared with noninduced or wild-type hearts, S68E expression in induced hearts was ∼35-75% that of endogenous PLM, but protein levels of sarco(endo)plasmic reticulum Ca2+ -ATPase, α1- and α2-subunits of Na+ -K+ -ATPase, α1c-subunit of L-type Ca2+ channel, and phosphorylated ryanodine receptor were unchanged. The NCX1 protein level was increased by ∼47% but the NCX1 current was depressed by ∼34% in induced hearts. Isoproterenol had no effect on NCX1 currents but stimulated Na+ -K+ -ATPase currents equally in induced and noninduced myocytes. At baseline, systolic intracellular Ca2+ concentrations ([Ca2+]i), sarcoplasmic reticulum Ca2+ contents, and [Ca(2+)]i transient and contraction amplitudes were similar between induced and noninduced myocytes. Isoproterenol stimulation resulted in much higher systolic [Ca2+]i, sarcoplasmic reticulum Ca2+ content, and [Ca2+]i transient and contraction amplitudes in induced myocytes. Echocardiography and in vivo close-chest catheterization demonstrated similar baseline myocardial function, but isoproterenol induced a significantly higher +dP/dt in induced compared with noninduced hearts. In contrast to the 50% mortality observed in mice constitutively overexpressing the S68E mutant, induced mice had similar survival as wild-type and noninduced mice. After ischemia-reperfusion, despite similar areas at risk and left ventricular infarct sizes, induced mice had significantly higher +dP/dt and -dP/dt and lower perioperative mortality compared with noninduced mice. We propose that phosphorylated PLM may be a novel therapeutic target in ischemic heart disease.

Duke Scholars

Published In

Am J Physiol Heart Circ Physiol

DOI

EISSN

1522-1539

Publication Date

April 1, 2014

Volume

306

Issue

7

Start / End Page

H1066 / H1077

Location

United States

Related Subject Headings

  • Ventricular Pressure
  • Ventricular Function, Left
  • Ventricular Dysfunction, Left
  • Up-Regulation
  • Stroke Volume
  • Sodium-Potassium-Exchanging ATPase
  • Sodium-Calcium Exchanger
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases
  • Sarcoplasmic Reticulum
  • Ryanodine Receptor Calcium Release Channel
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Wang, J., Song, J., Gao, E., Zhang, X.-Q., Gu, T., Yu, D., … Cheung, J. Y. (2014). Induced overexpression of phospholemman S68E mutant improves cardiac contractility and mortality after ischemia-reperfusion. Am J Physiol Heart Circ Physiol, 306(7), H1066–H1077. https://doi.org/10.1152/ajpheart.00861.2013
Wang, JuFang, Jianliang Song, Erhe Gao, Xue-Qian Zhang, Tongda Gu, Daohai Yu, Walter J. Koch, Arthur M. Feldman, and Joseph Y. Cheung. “Induced overexpression of phospholemman S68E mutant improves cardiac contractility and mortality after ischemia-reperfusion.Am J Physiol Heart Circ Physiol 306, no. 7 (April 1, 2014): H1066–77. https://doi.org/10.1152/ajpheart.00861.2013.
Wang J, Song J, Gao E, Zhang X-Q, Gu T, Yu D, et al. Induced overexpression of phospholemman S68E mutant improves cardiac contractility and mortality after ischemia-reperfusion. Am J Physiol Heart Circ Physiol. 2014 Apr 1;306(7):H1066–77.
Wang, JuFang, et al. “Induced overexpression of phospholemman S68E mutant improves cardiac contractility and mortality after ischemia-reperfusion.Am J Physiol Heart Circ Physiol, vol. 306, no. 7, Apr. 2014, pp. H1066–77. Pubmed, doi:10.1152/ajpheart.00861.2013.
Wang J, Song J, Gao E, Zhang X-Q, Gu T, Yu D, Koch WJ, Feldman AM, Cheung JY. Induced overexpression of phospholemman S68E mutant improves cardiac contractility and mortality after ischemia-reperfusion. Am J Physiol Heart Circ Physiol. 2014 Apr 1;306(7):H1066–H1077.

Published In

Am J Physiol Heart Circ Physiol

DOI

EISSN

1522-1539

Publication Date

April 1, 2014

Volume

306

Issue

7

Start / End Page

H1066 / H1077

Location

United States

Related Subject Headings

  • Ventricular Pressure
  • Ventricular Function, Left
  • Ventricular Dysfunction, Left
  • Up-Regulation
  • Stroke Volume
  • Sodium-Potassium-Exchanging ATPase
  • Sodium-Calcium Exchanger
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases
  • Sarcoplasmic Reticulum
  • Ryanodine Receptor Calcium Release Channel